A challenge in the prenatal management of FGR is differentiating the constitutionally small fetus with a normal neonatal outcome from one who is pathologically growth restricted and at risk for postnatal complications.
Adaptability and flexibility will be needed to deal with for challenges next year.
Curbside Consults delivers expert perspectives from physicians outside of the OB/GYN specialty to provide insight into various health issues affecting pregnant women. This new section is the brainchild of Editorial Advisory Board member Christine Isaacs, MD.
Providers can face criminal penalties under The Federal Travel Act & EKRA, too.
Discussions regarding health equity and access to care have long been implicated in breast cancer. Here, key opinion leaders discuss the latest progress in clinical trial access, digital therapeutics, and other efforts that aim to ameliorate these care gaps.
Extended combined hormonal contraceptive regimens, which include prolonged active hormone use and shorter hormone-free intervals, offer increased contraceptive efficacy, reduced menstrual symptoms, and improved management of withdrawal bleeding compared to traditional cyclic use.
In this study, investigators focused on children with Fetal Alcohol Spectrum Disorder (FASD), who are known to experience significant sleep disturbances.
More medical and SDOH (social determinants of health) data is available now than ever before to clinicians, health care organizations, and payors. Using this data can lead to better outcomes.
Recommendations for maternity care professionals based on MiPATH.
The Society of Ob/Gyn Hospitalists released a statement on the Supreme Court Decision overturning Roe v Wade.
Exploring the available interventions for acute pain management during the preoperative, intraoperative, and postoperative phases of care.
Panelists discuss strategies for simplifying complex information for primary care physicians (PCPs), provide tips on how PCPs can effectively communicate evidence-based treatment options to patients, and outline actionable points and key takeaways to enhance patient care in managing menopause symptoms.
Pediatricians, adolescent medicine physicians, and other youth providers can play a crucial role in mitigating this risk by supporting SMGD youth and their families and promoting resilience through inclusive and clinically, culturally competent care.
NIDA study shows significant gender difference, but reasons are uncertain.
Mauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, address gaps in care for the treatment of uterine fibroids and share the importance of patient education in disease management.
A recent study examined the links between breastfeeding and preterm birth history with hospitalization duration due to LRTIs in infants and toddlers.
Read one ob-gyn’s experience going unmatched and how she navigated the news in this Your Voice.
A 35-year-old woman presents with a rash on her face, which worsened following a sunburn on a beach trip and persisted for more than 6 months. What's the diagnosis?
On June 2, 2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls of reproductive age.
Technology may be used in ultrasounds, fetal heart rate interpretation, and prediction of adverse clinical outcomes.
A global study uncovers the widespread stigma, emotional toll, and workplace challenges women face during menopause, highlighting the urgent need for awareness, support, and personalized care.
Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Findings and significance for gynecologic surgeons.
Black patients may have poorer outcomes during breast cancer treatment than white patients.
Harnessing digital marketing tools can help your medical practice grow.
Here’s why we should be paying special attention to women’s depression treatment.
Perimenopausal, menopausal, and postmenopausal women experienced a progressive improvement in hair growth, shedding, quality of life, and menopausal symptoms after 12 months with an active nutraceutical supplement.